Literature DB >> 10481816

Assessing "best evidence": issues in grading the quality of studies for systematic reviews.

K N Lohr1, T S Carey.   

Abstract

BACKGROUND: Evidence-based medicine, clinical practice guidelines, quality and value of health services, and science-based decision making are becoming mainstays of the health care sector. As part of the evidence-based movement, systematic reviews of the literature on clinical questions are becoming increasingly common. Part of the structured approach to evaluating the literature involves assessing the quality of individual studies included in systematic reviews. REVIEW QUESTIONS: To clarify issues in this area, in 1998 the Agency for Health Care Policy and Research commissioned a small project to determine how its 12 Evidence-based Practice Centers were carrying out this part of their systematic reviews (called evidence reports). The number of potential checklists, scales, and similar tools for grading the methodology or the clinical relevance of individual reports is large; the reliability, the validity, the feasibility, and the utility of these tools are either unmeasured or quite variable.
CONCLUSIONS: Numerous methodologic questions await definitive research and answers, but in the meantime teams developing authoritative systematic reviews can take certain steps to ensure that their approaches to grading the quality of articles meet applicable scientific standards. Clinicians, program administrators, and health policymakers can then be confident in the overall strength of the evidence and study conclusions.

Entities:  

Mesh:

Year:  1999        PMID: 10481816     DOI: 10.1016/s1070-3241(16)30461-8

Source DB:  PubMed          Journal:  Jt Comm J Qual Improv        ISSN: 1070-3241


  15 in total

1.  Comparability work and the management of difference in research synthesis studies.

Authors:  Margarete Sandelowski; Corrine I Voils; Julie Barroso
Journal:  Soc Sci Med       Date:  2006-10-09       Impact factor: 4.634

Review 2.  Medicare part D and long-term care: a systematic review of quantitative and qualitative evidence.

Authors:  Camilla B Pimentel; Kate L Lapane; Becky A Briesacher
Journal:  Drugs Aging       Date:  2013-09       Impact factor: 3.923

3.  Methodological quality in medical evidence, quo vadis?

Authors:  Mireya Diaz-Insua
Journal:  Ther Adv Urol       Date:  2009-04

Review 4.  Soil-transmitted Helminthiasis in the United States: a systematic review--1940-2010.

Authors:  Michelle C Starr; Susan P Montgomery
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

Review 5.  Medication adherence interventions that target subjects with adherence problems: Systematic review and meta-analysis.

Authors:  Vicki S Conn; Todd M Ruppar; Maithe Enriquez; Pam Cooper
Journal:  Res Social Adm Pharm       Date:  2015-06-15

6.  Chapter 7: grading a body of evidence on diagnostic tests.

Authors:  Sonal Singh; Stephanie M Chang; David B Matchar; Eric B Bass
Journal:  J Gen Intern Med       Date:  2012-06       Impact factor: 5.128

7.  A Guide for applying a revised version of the PARIHS framework for implementation.

Authors:  Cheryl B Stetler; Laura J Damschroder; Christian D Helfrich; Hildi J Hagedorn
Journal:  Implement Sci       Date:  2011-08-30       Impact factor: 7.327

8.  Pelvic floor muscle training and adjunctive therapies for the treatment of stress urinary incontinence in women: a systematic review.

Authors:  Patricia B Neumann; Karen A Grimmer; Yamini Deenadayalan
Journal:  BMC Womens Health       Date:  2006-06-28       Impact factor: 2.809

9.  Evaluating the role of quality assessment of primary studies in systematic reviews of cancer practice guidelines.

Authors:  Melissa C Brouwers; Mary E Johnston; Manya L Charette; Steve E Hanna; Alejandro R Jadad; George P Browman
Journal:  BMC Med Res Methodol       Date:  2005-02-16       Impact factor: 4.615

10.  Development and evaluation of an instrument for the critical appraisal of randomized controlled trials of natural products.

Authors:  Tannis Jurgens; Anne Marie Whelan; Melissa MacDonald; Lindsay Lord
Journal:  BMC Complement Altern Med       Date:  2009-04-23       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.